241 related articles for article (PubMed ID: 15743896)
1. Topical microbicides for the prevention of genital herpes infection.
Keller MJ; Tuyama A; Carlucci MJ; Herold BC
J Antimicrob Chemother; 2005 Apr; 55(4):420-3. PubMed ID: 15743896
[TBL] [Abstract][Full Text] [Related]
2. Antivirals in the prevention of genital herpes.
Au E; Sacks SL
Herpes; 2002 Dec; 9(3):74-7. PubMed ID: 12470605
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
Madan RP; Keller MJ; Herold BC
Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
Drake AL; John-Stewart GC; Wald A; Mbori-Ngacha DA; Bosire R; Wamalwa DC; Lohman-Payne BL; Ashley-Morrow R; Corey L; Farquhar C
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):403-9. PubMed ID: 17267842
[TBL] [Abstract][Full Text] [Related]
5. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
Nikolic DS; Garcia E; Piguet V
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
[TBL] [Abstract][Full Text] [Related]
6. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.
Thurman AR; Doncel GF
Int J STD AIDS; 2012 Sep; 23(9):613-9. PubMed ID: 23033511
[TBL] [Abstract][Full Text] [Related]
8. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
9. Genital herpes in young adults: changing sexual behaviours, epidemiology and management.
Roberts C
Herpes; 2005 Jun; 12(1):10-4. PubMed ID: 16026639
[TBL] [Abstract][Full Text] [Related]
10. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
[TBL] [Abstract][Full Text] [Related]
11. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
12. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
Keller MJ; Herold BC
Am J Reprod Immunol; 2006; 56(5-6):356-63. PubMed ID: 17076680
[TBL] [Abstract][Full Text] [Related]
13. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
14. Microbicides for preventing transmission of genital herpes.
Zeitlin L; Whaley KJ
Herpes; 2002 Apr; 9(1):4-9. PubMed ID: 11916493
[TBL] [Abstract][Full Text] [Related]
15. Interrupting herpes simplex virus type 2 transmission: the role of condoms and microbicides.
Langenberg A
Herpes; 2004 Aug; 11 Suppl 3():147A-154A. PubMed ID: 15319084
[TBL] [Abstract][Full Text] [Related]
16. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus.
Chen KT; Segú M; Lumey LH; Kuhn L; Carter RJ; Bulterys M; Abrams EJ;
Obstet Gynecol; 2005 Dec; 106(6):1341-8. PubMed ID: 16319261
[TBL] [Abstract][Full Text] [Related]
17. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
19. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus in pregnancy: new concepts in prevention and management.
Hill J; Roberts S
Clin Perinatol; 2005 Sep; 32(3):657-70. PubMed ID: 16085025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
